Novo Nordisk announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option for adults living with obesity and overweight who present with at least one weight-related comorbidity.
Novo Nordisk Launches Obesity Medicine Wegovy (Semaglutide 2.4mg) in Malaysia
Posted on